• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 9/26/24: How Pharma Can Reach Sustainability Goals, Takeaways from Senate Semaglutide Pricing Hearing & more

News
Article

The latest news for pharma industry insiders.

LogiPharma USA 2024: How Pharma Can Reach Its Sustainability Goals

A panel discussion regarding "How Pharma Can Better Understand Its Carbon Footprint and Reach Sustainability Goals" convened yesterday, and was moderated by Joe Van Der Bosch, president of DeSpir Logistics. He was joined by Alaina Passavant, account manager, CDP Supply Chain; Kaushik Datta, a pharma supply chain expert, Chandan Trehan, digital supply chain & sustainability Lead with Bosch; Jeff Tucker, CEO, Tucker Company Worldwide, and Joe McCannon, director for sustainability at the Office of the Federal Chief Sustainability Officer, Council on Environmental Quality (CEG).

Takeaways from Senate Hearing on Semaglutide Pricing

Novo Nordisk said it’s open to discussions with PBMs based on their commitments that a lower semgalutide list price would not impact formulary coverage.

Roche Narrows Pharma Pipeline Amid Push Into Obesity Market

The company cut about 25% of its pipeline, said Teresa Graham, chief of Roche’s pharma division.

New Publication Evaluates Awareness of High Breast Density as a Risk Factor for Breast Cancer

In honor of World Dense Breast Day on September 25, Bayer announced today a new study, published in Patient Preference and Adherence, evaluating awareness and knowledge gaps of breast cancer risk factors among women with and without high breast density (HBD). The study, a web-based survey, found only 39 percent were familiar with the concept of HBD in the context of breast cancer, and 31 percent were aware of HBD as a Breast Cancer Risk Factor.

The Northeast Science & Technology Center on LinkedIn

Thank you to Pharmaceutical Executive's Miranda Schmalfuhs for interviewing Jonathan Scheinberg about mega campuses in the life sciences sector. The Northeast Science & Technology (NEST) Center is a prime example of a repurposed mega campus, creating an innovative ecosystem for life sciences to thrive.

#LifeSciences #MegaCampus #PharmaInnovation #NEST #Biotech #RandD
#BigPharma #FutureOfScience #NESTCenter #RealEstate #CommercialR

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs